79 related articles for article (PubMed ID: 25886454)
1. DNA copy number analysis of metastatic urothelial carcinoma with comparison to primary tumors.
Bambury RM; Bhatt AS; Riester M; Pedamallu CS; Duke F; Bellmunt J; Stack EC; Werner L; Park R; Iyer G; Loda M; Kantoff PW; Michor F; Meyerson M; Rosenberg JE
BMC Cancer; 2015 Apr; 15():242. PubMed ID: 25886454
[TBL] [Abstract][Full Text] [Related]
2. Common germline-somatic variant interactions in advanced urothelial cancer.
Vosoughi A; Zhang T; Shohdy KS; Vlachostergios PJ; Wilkes DC; Bhinder B; Tagawa ST; Nanus DM; Molina AM; Beltran H; Sternberg CN; Motanagh S; Robinson BD; Xiang J; Fan X; Chung WK; Rubin MA; Elemento O; Sboner A; Mosquera JM; Faltas BM
Nat Commun; 2020 Dec; 11(1):6195. PubMed ID: 33273457
[TBL] [Abstract][Full Text] [Related]
3. Organoid generation from mouse mammary tumors captures the genetic heterogeneity of clinically relevant copy number alterations.
Lake KE; Colonetta MM; Smith CA; Martinez-Algarin K; Saunders K; Mohta S; Pena J; McArthur HL; Reddy SM; Roussos-Torres ET; Chen EH; Chan IS
bioRxiv; 2023 Jan; ():. PubMed ID: 36778256
[TBL] [Abstract][Full Text] [Related]
4. Digital droplet PCR analysis of organoids generated from mouse mammary tumors demonstrates proof-of-concept capture of tumor heterogeneity.
Lake KE; Colonnetta MM; Smith CA; Saunders K; Martinez-Algarin K; Mohta S; Pena J; McArthur HL; Reddy SM; Roussos Torres ET; Chen EH; Chan IS
Front Cell Dev Biol; 2024; 12():1358583. PubMed ID: 38827528
[TBL] [Abstract][Full Text] [Related]
5. Integrative clinical genomics of advanced prostate cancer.
Robinson D; Van Allen EM; Wu YM; Schultz N; Lonigro RJ; Mosquera JM; Montgomery B; Taplin ME; Pritchard CC; Attard G; Beltran H; Abida W; Bradley RK; Vinson J; Cao X; Vats P; Kunju LP; Hussain M; Feng FY; Tomlins SA; Cooney KA; Smith DC; Brennan C; Siddiqui J; Mehra R; Chen Y; Rathkopf DE; Morris MJ; Solomon SB; Durack JC; Reuter VE; Gopalan A; Gao J; Loda M; Lis RT; Bowden M; Balk SP; Gaviola G; Sougnez C; Gupta M; Yu EY; Mostaghel EA; Cheng HH; Mulcahy H; True LD; Plymate SR; Dvinge H; Ferraldeschi R; Flohr P; Miranda S; Zafeiriou Z; Tunariu N; Mateo J; Perez-Lopez R; Demichelis F; Robinson BD; Schiffman M; Nanus DM; Tagawa ST; Sigaras A; Eng KW; Elemento O; Sboner A; Heath EI; Scher HI; Pienta KJ; Kantoff P; de Bono JS; Rubin MA; Nelson PS; Garraway LA; Sawyers CL; Chinnaiyan AM
Cell; 2015 May; 161(5):1215-1228. PubMed ID: 26000489
[TBL] [Abstract][Full Text] [Related]
6. Human genomics. Effect of predicted protein-truncating genetic variants on the human transcriptome.
Rivas MA; Pirinen M; Conrad DF; Lek M; Tsang EK; Karczewski KJ; Maller JB; Kukurba KR; DeLuca DS; Fromer M; Ferreira PG; Smith KS; Zhang R; Zhao F; Banks E; Poplin R; Ruderfer DM; Purcell SM; Tukiainen T; Minikel EV; Stenson PD; Cooper DN; Huang KH; Sullivan TJ; Nedzel J; ; ; Bustamante CD; Li JB; Daly MJ; Guigo R; Donnelly P; Ardlie K; Sammeth M; Dermitzakis ET; McCarthy MI; Montgomery SB; Lappalainen T; MacArthur DG
Science; 2015 May; 348(6235):666-9. PubMed ID: 25954003
[TBL] [Abstract][Full Text] [Related]
7. Human genomics. The human transcriptome across tissues and individuals.
Melé M; Ferreira PG; Reverter F; DeLuca DS; Monlong J; Sammeth M; Young TR; Goldmann JM; Pervouchine DD; Sullivan TJ; Johnson R; Segrè AV; Djebali S; Niarchou A; ; Wright FA; Lappalainen T; Calvo M; Getz G; Dermitzakis ET; Ardlie KG; Guigó R
Science; 2015 May; 348(6235):660-5. PubMed ID: 25954002
[TBL] [Abstract][Full Text] [Related]
8. Somatic Copy Number Abnormalities and Mutations in PI3K/AKT/mTOR Pathway Have Prognostic Significance for Overall Survival in Platinum Treated Locally Advanced or Metastatic Urothelial Tumors.
Bellmunt J; Werner L; Leow JJ; Mullane SA; Fay AP; Riester M; Van Hummelen P; Taplin ME; Choueiri TK; Van Allen E; Rosenberg J
PLoS One; 2015; 10(6):e0124711. PubMed ID: 26039708
[TBL] [Abstract][Full Text] [Related]
9. Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma.
Michaelson MD; McKay RR; Werner L; Atkins MB; Van Allen EM; Olivier KM; Song J; Signoretti S; McDermott DF; Choueiri TK
Cancer; 2015 Oct; 121(19):3435-43. PubMed ID: 26058385
[TBL] [Abstract][Full Text] [Related]
10. Super enhancer-driven core transcriptional regulatory circuitry crosstalk with cancer plasticity and patient mortality in triple-negative breast cancer.
Shi W; Zhong B; Dong J; Hu X; Li L
Front Genet; 2023; 14():1258862. PubMed ID: 37900187
[TBL] [Abstract][Full Text] [Related]
11. The clonal heterogeneity of colon cancer with liver metastases.
Chen G; Zhu W; Liu Y; Zhang L; Xie L; Song X; Song X
J Gastroenterol; 2023 Jul; 58(7):642-655. PubMed ID: 37042990
[TBL] [Abstract][Full Text] [Related]
12. Recurrent glioblastoma metastatic to the lumbar vertebra: A case report and literature review: Surgical oncology.
Matsuhashi A; Tanaka S; Takami H; Nomura M; Ikemura M; Matsubayashi Y; Shinoda Y; Yamada K; Sakai Y; Karasawa Y; Takayanagi S; Saito N
Front Oncol; 2023; 13():1101552. PubMed ID: 36874120
[TBL] [Abstract][Full Text] [Related]
13. Integrated Genomic and Transcriptomic Analysis reveals key genes for predicting dual-phenotype Hepatocellular Carcinoma Prognosis.
Wang Y; Wang X; Huang X; Zhang J; Hu J; Qi Y; Xiang B; Wang Q
J Cancer; 2021; 12(10):2993-3010. PubMed ID: 33854600
[TBL] [Abstract][Full Text] [Related]
14. Combination of Genome-Wide Polymorphisms and Copy Number Variations of Pharmacogenes in Koreans.
Han N; Oh JM; Kim IW
J Pers Med; 2021 Jan; 11(1):. PubMed ID: 33430289
[TBL] [Abstract][Full Text] [Related]
15. The biology and rationale of targeting nectin-4 in urothelial carcinoma.
Heath EI; Rosenberg JE
Nat Rev Urol; 2021 Feb; 18(2):93-103. PubMed ID: 33239713
[TBL] [Abstract][Full Text] [Related]
16. Two cases of osteoblastic bone metastasis from muscle-invasive bladder cancer with discrepancy in response to chemotherapy: problems and limitations of bone biopsy.
Ogasawara T; Tanaka T; Shindo T; Hashimoto K; Fukuta F; Kobayashi K; Sugawara T; Hasegawa T; Masumori N
Int Cancer Conf J; 2020 Oct; 9(4):235-239. PubMed ID: 32904051
[TBL] [Abstract][Full Text] [Related]
17. MCL1 and DEDD Promote Urothelial Carcinoma Progression.
Hong AL; Guerriero JL; Doshi MB; Kynnap BD; Kim WJ; Schinzel AC; Modiste R; Schlauch AJ; Adam RM; Kwiatkowski DJ; Beroukhim R; Letai A; Rosenberg JE; Hahn WC
Mol Cancer Res; 2019 Jun; 17(6):1294-1304. PubMed ID: 30777879
[TBL] [Abstract][Full Text] [Related]
18. aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin- or Irinotecan-Based Chemotherapy in Patients with Metastatic Colorectal Cancer.
Fujita Y; Taguri M; Yamazaki K; Tsurutani J; Sakai K; Tsushima T; Nagase M; Tamagawa H; Ueda S; Tamura T; Tsuji Y; Murata K; Taira K; Denda T; Moriwaki T; Funai S; Nakajima TE; Muro K; Tsuji A; Yoshida M; Suyama K; Kurimoto T; Sugimoto N; Baba E; Seki N; Sato M; Shimura T; Boku N; Hyodo I; Yamanaka T; Nishio K
Oncologist; 2019 Mar; 24(3):327-337. PubMed ID: 30425180
[TBL] [Abstract][Full Text] [Related]
19. Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma.
Gopal RK; Kübler K; Calvo SE; Polak P; Livitz D; Rosebrock D; Sadow PM; Campbell B; Donovan SE; Amin S; Gigliotti BJ; Grabarek Z; Hess JM; Stewart C; Braunstein LZ; Arndt PF; Mordecai S; Shih AR; Chaves F; Zhan T; Lubitz CC; Kim J; Iafrate AJ; Wirth L; Parangi S; Leshchiner I; Daniels GH; Mootha VK; Dias-Santagata D; Getz G; McFadden DG
Cancer Cell; 2018 Aug; 34(2):242-255.e5. PubMed ID: 30107175
[TBL] [Abstract][Full Text] [Related]
20. Comparative molecular characterization of typical and exceptional responders in glioblastoma.
Wipfler K; Cornish AS; Guda C
Oncotarget; 2018 Jun; 9(47):28421-28433. PubMed ID: 29983870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
